Ya Gao

Key Laboratory For Chemistry And Molecular Engineering Of Medicinal Resources
Guilin, 541004, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Multifunctional Lanthanide Molecular Ferroelectrics [R/S-H2MPPA][Ln(btfa)4]2 Constructed by Hydrogen Bond Linking Functional Blocks.

Multifunctional Lanthanide Molecular Ferroelectrics [R/S-H2MPPA][Ln(btfa)4]2 Constructed by Hydrogen Bond Linking Functional Blocks.

Journal: Inorganic chemistry

Published: February 24, 2026

Dicliptera chinensis (L.) Juss. polysaccharide alleviates metabolic dysfunction-associated steatotic liver disease by regulating miR-3073b-5p/CAMKK2 via the gut microbiota-bile acid axis.

Dicliptera chinensis (L.) Juss. polysaccharide alleviates metabolic dysfunction-associated steatotic liver disease by regulating miR-3073b-5p/CAMKK2 via the gut microbiota-bile acid axis.

Journal: International journal of biological macromolecules

Published: February 06, 2026

Scoparone ameliorates metabolic dysfunction-associated steatotic liver disease by regulating the miR-3073a-3p/CAMKK2 axis.

Scoparone ameliorates metabolic dysfunction-associated steatotic liver disease by regulating the miR-3073a-3p/CAMKK2 axis.

Journal: Journal of ethnopharmacology

Published: December 28, 2025

Sophoricoside ameliorates LPS/D-GalN-induced acute liver failure by inhibiting ferroptosis via activation of the Nrf2/GPX4 signaling pathway.

Sophoricoside ameliorates LPS/D-GalN-induced acute liver failure by inhibiting ferroptosis via activation of the Nrf2/GPX4 signaling pathway.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: July 19, 2025

Taraxasterol extracted from Ixeridium gramineum (Fisch.) Tzvel. Attenuated D-GalN/LPS-induced fulminant hepatitis by modulating the JAK/STAT and TNF signalling pathways.

Taraxasterol extracted from Ixeridium gramineum (Fisch.) Tzvel. Attenuated D-GalN/LPS-induced fulminant hepatitis by modulating the JAK/STAT and TNF signalling pathways.

Journal: Journal of ethnopharmacology

Published: July 15, 2024

Polygala fallax Hemsl polysaccharides alleviated alcoholic fatty liver disease by modifying lipid metabolism via AMPK.

Polygala fallax Hemsl polysaccharides alleviated alcoholic fatty liver disease by modifying lipid metabolism via AMPK.

Journal: International journal of biological macromolecules

Published: June 10, 2024

Desmodium styracifolium (Osb.) Merr. Extracts alleviate cholestatic liver disease by FXR pathway.

Desmodium styracifolium (Osb.) Merr. Extracts alleviate cholestatic liver disease by FXR pathway.

Journal: Journal of ethnopharmacology

Published: June 10, 2024

Polysaccharide of Dicliptera chinensis (L.) Juss. alleviated cholestatic liver disease by modulating the FXR pathway.

Polysaccharide of Dicliptera chinensis (L.) Juss. alleviated cholestatic liver disease by modulating the FXR pathway.

Journal: International journal of biological macromolecules

Published: May 22, 2024

Mechanistic studies on the alleviation of ANIT-induced cholestatic liver injury by Polygala fallax Hemsl. polysaccharides.

Mechanistic studies on the alleviation of ANIT-induced cholestatic liver injury by Polygala fallax Hemsl. polysaccharides.

Journal: Journal of ethnopharmacology

Published: November 20, 2023

The Effect of Bergenin on Isonicotinic Acid Hydrazide and Rifampicin-Induced Liver Injury Revealed by RNA Sequencing.

The Effect of Bergenin on Isonicotinic Acid Hydrazide and Rifampicin-Induced Liver Injury Revealed by RNA Sequencing.

Journal: Molecules (Basel, Switzerland)

Published: June 08, 2023

The effects of scoparone on alcohol and high-fat diet-induced liver injury revealed by RNA sequencing.

The effects of scoparone on alcohol and high-fat diet-induced liver injury revealed by RNA sequencing.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 09, 2022

Effects of scoparone on non-alcoholic fatty liver disease revealed by RNA sequencing.

Effects of scoparone on non-alcoholic fatty liver disease revealed by RNA sequencing.

Journal: Frontiers in endocrinology

Published: July 27, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026